BACKGROUND: Risk stratification is currently recommended for the initial management of patients with acute pulmonary embolism (PE). METHODS: We performed a meta-analysis of studies in patients with acute PE to assess the prognostic value of elevated D-dimer levels for short-term (within 30 days) and 3-month mortality. The association between D-dimer levels and markers of PE severity was also reviewed. Unrestricted searches were performed using the terms D-dimer and pulmonary embolism. Studies reporting on D-dimer levels and mortality and/or markers of PE severity were included in the review. A random-effects model was used to pool study results, funnel-plot inspection to evaluate publication bias and I squared testing to test for heterogeneity. RESULTS: Five studies (2,885 patients) reported on D-dimer levels and short-term mortality. D-dimer levels above a prognostic cut-off were significantly associated with short-term mortality in the overall population (OR: 2.76; 95% CI: 1.83-4.14; I(2) = 0%) and in hemodynamically stable patients (three studies, 874 patients; OR: 4.28; 95% CI: 1.88-9.71; I(2) = 0%). Four studies (1,254 patients) reported on D-dimer levels and 3-month mortality. D-dimer levels above a prognostic cut-off were associated with 3-month mortality (OR: 4.29; 95% IC: 1.70-10.79; I(2) = 0%). Overall, 14 studies assessed the association between D-dimer and markers of PE severity. An association has been observed between D-dimer levels and the degree of pulmonary artery obstruction. CONCLUSION: In patients with acute PE elevated D-dimer is associated with increased short-term and 3-month mortality, suggesting the potential of using this test for both diagnosis and risk stratification.
BACKGROUND: Risk stratification is currently recommended for the initial management of patients with acute pulmonary embolism (PE). METHODS: We performed a meta-analysis of studies in patients with acute PE to assess the prognostic value of elevated D-dimer levels for short-term (within 30 days) and 3-month mortality. The association between D-dimer levels and markers of PE severity was also reviewed. Unrestricted searches were performed using the terms D-dimer and pulmonary embolism. Studies reporting on D-dimer levels and mortality and/or markers of PE severity were included in the review. A random-effects model was used to pool study results, funnel-plot inspection to evaluate publication bias and I squared testing to test for heterogeneity. RESULTS: Five studies (2,885 patients) reported on D-dimer levels and short-term mortality. D-dimer levels above a prognostic cut-off were significantly associated with short-term mortality in the overall population (OR: 2.76; 95% CI: 1.83-4.14; I(2) = 0%) and in hemodynamically stable patients (three studies, 874 patients; OR: 4.28; 95% CI: 1.88-9.71; I(2) = 0%). Four studies (1,254 patients) reported on D-dimer levels and 3-month mortality. D-dimer levels above a prognostic cut-off were associated with 3-month mortality (OR: 4.29; 95% IC: 1.70-10.79; I(2) = 0%). Overall, 14 studies assessed the association between D-dimer and markers of PE severity. An association has been observed between D-dimer levels and the degree of pulmonary artery obstruction. CONCLUSION: In patients with acute PE elevated D-dimer is associated with increased short-term and 3-month mortality, suggesting the potential of using this test for both diagnosis and risk stratification.
Authors: Charles V Pollack; Donald Schreiber; Samuel Z Goldhaber; David Slattery; John Fanikos; Brian J O'Neil; James R Thompson; Brian Hiestand; Beau A Briese; Robert C Pendleton; Chadwick D Miller; Jeffrey A Kline Journal: J Am Coll Cardiol Date: 2011-02-08 Impact factor: 24.094
Authors: Süleyman Türedi; Süleyman Caner Karahan; Ahmet Menteşe; Abdülkadir Gündüz; Murat Topbaş; Polat Koşucu; Funda Oztuna; Ozgür Tatli Journal: Anadolu Kardiyol Derg Date: 2010-08
Authors: Silvy Laporte; Patrick Mismetti; Hervé Décousus; Fernando Uresandi; Remedios Otero; Jose Luis Lobo; Manuel Monreal Journal: Circulation Date: 2008-03-17 Impact factor: 29.690
Authors: F A Klok; R Karami Djurabi; M Nijkeuter; H C J Eikenboom; F W G Leebeek; M H H Kramer; K Kaasjager; P W Kamphuisen; H R Büller; M V Huisman Journal: Br J Haematol Date: 2007-11-19 Impact factor: 6.998
Authors: Enric Grau; José María Tenías; María José Soto; María Reyes Gutierrez; Ramón Lecumberri; José Luís Pérez; Gregorio Tiberio Journal: Crit Care Med Date: 2007-08 Impact factor: 7.598
Authors: Thomas Walter; Paul Apfaltrer; Frank Weilbacher; Mathias Meyer; Stefan O Schoenberg; Christian Fink; Joachim Gruettner Journal: Exp Ther Med Date: 2012-11-22 Impact factor: 2.447